Molcovir 200Mg - Anti-COVID Generic Drug Molnupiravir

Molcovir 200Mg - Anti-COVID Generic Drug Molnupiravir

Enquiry Now


Description



Molnupiravir, an Oral Antiviral Treatment for COVID-19

200 Mg  Molcovir -molnupiravir 200mg



Packaging Size 10 Capsule
Composition Molnupiravir
Treatment Covid 19
Strength 200 Mg
Prescription/Non prescription Prescription
Brand Molcovir
Form Capsule
Shelf life 2 Years
Country of Origin

Made in India




PRE ORDER ONLY DELIVERY EXPECTED DEC 2021







Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics.




Additional Information

200 Mg Molcovir -molnupiravir 200mg


You May Also Like...

TESTIMONIALS